| | | | | (Reuters) - U.S. regulators approved Novartis' cell therapy Kymriah for treatment of patients with a second type of blood cancer, large B-cell lymphoma, that has worsened despite two or more earlier lines of therapy, the Swiss drugmaker said on Tuesday. | | |
| | | (Reuters) - U.S. regulators on Tuesday issued warnings to 13 companies selling e-cigarette liquids for using child-friendly images in their packaging, in the latest crackdown aimed at preventing tobacco sales to minors. | | |
| | | NEW YORK (Reuters) - The number of Americans sickened each year by bites from infected mosquitoes, ticks or fleas tripled from 2004 through 2016, with infection rates spiking sharply in 2016 as a result of a Zika outbreak, U.S. health officials said on Tuesday. | | |
| | | NEW DELHI (Reuters) - India has told the United States it won't abstain from capping prices for more medical devices, regardless of pressure to rethink its stance after price controls on heart stents and knee implants spoilt the market for some U.S. firms, sources familiar with the matter said. | | |
| | | (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday. | | |
| | | LONDON (Reuters) - Scotland introduced minimum unit pricing on alcohol on Tuesday as it tries to improve public health by raising the cost of cheap, strong drinks favored by young people and binge-drinkers. | | |
| | | (Reuters) - Combining intensive psychotherapy with a pure form of the party drug ecstasy is safe and could aid recovery in people with post-traumatic stress disorder (PTSD), according to the findings of a study in military veterans. | | |
| | | (Reuters Health) - Physicians' employers should commit to gender equity in pay, leadership development, career opportunities, and parental and family leave policies, a leading U.S. doctors group recommends. | | |
| | | (Reuters Health) - Distributing take-home overdose prevention kits substantially reduced the number of deaths from opioid overdoses in a Canadian province, researchers say. | | |
| | | SEOUL (Reuters) - South Korean biotech drug manufacturer Samsung BioLogics Co Ltd lost almost $6 billion in market value on Wednesday in its biggest intra-day share drop, after the country's financial watchdog said it breached accounting rules. | | |
|
| |
